Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05653999 · ClinicalTrials.gov registry record

Assessing Speech Perception and Amplification Benefit During Infancy

A clinical trial, sponsored by University of Colorado, Denver.

Completed
Registry status
36
Enrollment target

NCT05653999 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05653999 has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
36 participants
Enrollment target

Study Summary

The goal of this project is to compare aided and unaided speech discrimination among infants with hearing loss and a cohort of infants with typical hearing. Working Hypothesis: Among this group of infants with hearing loss, performance will be significantly better when infants are tested while using amplification (i.e., aided condition) compared to when tested without amplification (i.e., unaided condition). Infants fit with optimally programmed amplification will perform similarly to the infants with typical hearing on speech discrimination tasks.

Interventions

  • DEVICE Hearing Aids

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-03-10
Est. Completion 2025-05-28

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT05653999

The ClinicalTrials.gov registry entry for NCT05653999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hearing Aids is the first listed.

NCT05653999 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05653999 about?

NCT05653999 is a clinical study titled "Assessing Speech Perception and Amplification Benefit During Infancy". The goal of this project is to compare aided and unaided speech discrimination among infants with hearing loss and a cohort of infants with typical hearing. Working Hypothesis: Among this group of infants with hearing loss, performance will be significantly better when infants are tested while usin...

What is the current status of trial NCT05653999?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2023-03-10. Estimated completion is 2025-05-28.

What interventions are being tested in trial NCT05653999?

The interventions under investigation include: Hearing Aids (DEVICE).

Who is sponsoring clinical trial NCT05653999?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.